Pulmatrix (PULM) Long-Term Debt Issuances (2013 - 2018)
Pulmatrix (PULM) posted Long-Term Debt Issuances of -$2.5 million for Q2 2018, down 253.27% sequentially from -$719000.0 in Q1 2018, and down 282.53% YoY from $1.4 million in Q2 2017.
Pulmatrix (PULM) Long-Term Debt Issuances (2013 - 2018) Analysis & Trends
Pulmatrix has reported Long-Term Debt Issuances for 6 years, with the latest figure at -$2.5 million in Q2 2018.
- Quarterly Long-Term Debt Issuances fell 282.53% year-over-year to -$2.5 million in Q2 2018, while the trailing twelve-month figure through Sep 2020 was -$2.5 million (changed N/A YoY) and the FY2020 annual result came in at $617000.0, changed N/A from the prior year.
- Long-Term Debt Issuances slipped to -$2.5 million in Q2 2018 per PULM's latest filing, from -$719000.0 in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $6.9 million in Q2 2015 and troughed at -$2.5 million in Q2 2018.
- A 5-year average of $1.8 million and a median of -$642500.0 in 2016 frame the typical range for Long-Term Debt Issuances.
- The sharpest annual moves came in 2015 and 2018: Long-Term Debt Issuances soared 36.83% in 2015, then tumbled 282.53% in 2018.
- Over 5 years, Long-Term Debt Issuances stood at $6.9 million in 2014, then plunged by 35.17% to $4.5 million in 2015, then sank by 114.22% to -$634000.0 in 2016, then decreased by 10.41% to -$700000.0 in 2017, then slumped by 262.86% to -$2.5 million in 2018.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered -$2.5 million, -$719000.0, and -$700000.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -2.54 Mn |
| Jun 30, 2018 | -2.54 Mn |
| Mar 31, 2018 | -719,000.00 |
| Mar 31, 2018 | -719,000.00 |
| Dec 31, 2017 | -700,000.00 |
| Dec 31, 2017 | -700,000.00 |
| Sep 30, 2017 | -680,000.00 |
| Sep 30, 2017 | -680,000.00 |
| Jun 30, 2017 | -664,000.00 |
| Jun 30, 2017 | -664,000.00 |
| Mar 31, 2017 | -651,000.00 |
| Mar 31, 2017 | -651,000.00 |
| Dec 31, 2016 | -634,000.00 |
| Dec 31, 2016 | -634,000.00 |
| Sep 30, 2015 | 4.46 Mn |
| Sep 30, 2015 | 4.46 Mn |
| Jun 30, 2015 | 6.91 Mn |
| Jun 30, 2015 | 6.91 Mn |
| Mar 31, 2015 | 4.50 Mn |
| Mar 31, 2015 | 4.50 Mn |